Copenhagen, Denmark

Paul Cloos



Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paul Cloos: Innovator in Pharmaceutical Methods

Introduction

Paul Cloos is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for testing compounds that may aid in cancer treatment. With a total of 2 patents, his work has the potential to impact clinical practices significantly.

Latest Patents

One of his latest patents is focused on the inhibition of GASC1. This invention provides a method for testing the ability of a test compound to bind to and modulate the activity of a protein from the JMJD2 subfamily of Jumonji proteins. The method involves incubating a test compound with the protein, a co-factor, and optionally a substrate for demethylation. This innovative approach can screen numerous compounds to identify candidates for clinical use, particularly in treating certain cancers, especially prostate cancer. Another patent addresses the assay of D-amino acids in body fluids. This method determines the degradation rate of a body protein by measuring the amount of a D-amino acid containing fragment in a body fluid using a specific antibody. This technique has significant implications for understanding protein degradation in vivo.

Career Highlights

Throughout his career, Paul Cloos has worked with various organizations, including Osteometer Biotech A/S and Københavns Universitet. His experience in these institutions has allowed him to develop and refine his innovative methods, contributing to advancements in the pharmaceutical industry.

Collaborations

Paul has collaborated with notable individuals such as Christian Fledelius and Per Qvist. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions.

Conclusion

Paul Cloos is a distinguished inventor whose work in pharmaceutical methods showcases his commitment to advancing cancer treatment. His innovative patents reflect his expertise and dedication to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…